In multivariable regression models adjusted for baseline patient characteristics, NSAID-reactive patients were still more likely to develop opioid use disorder than those in the osteoarthritis cohort without documented NSAID allergy (OR, 1.70) and than in those with non-NSAID allergy (OR, 1.53).